Concepedia

Publication | Closed Access

Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis

DOI

180

Citations

38

References

2004

Year

Thomas J. Hoerger, Russell Harris, Katherine A. Hicks, Katrina E Donahue, Stephen W. Sorensen, Michael M. Engelgau
Annals of Internal Medicine

Abstract

Diabetes screening targeted to people with hypertension is more cost-effective than universal screening. The most cost-effective strategy is targeted screening at age 55 to 75 years.

References

YearCitations

Page 1